Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5189492
Max Phase: Preclinical
Molecular Formula: C59H75BF2N10O8
Molecular Weight: 1101.12
Associated Items:
ID: ALA5189492
Max Phase: Preclinical
Molecular Formula: C59H75BF2N10O8
Molecular Weight: 1101.12
Associated Items:
Canonical SMILES: Cc1cc(C)n2c1C=C1C=CC(CCC(=O)NCCCC[C@H](NC(=O)CCNC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](Cc3ccccc3)NC(=O)CCN3CCC(Oc4ccccc4Cc4ccccc4)CC3)C(N)=O)=[N+]1[B-]2(F)F
Standard InChI: InChI=1S/C59H75BF2N10O8/c1-39-35-40(2)71-51(39)38-47-23-22-46(72(47)60(71,61)62)24-25-53(73)64-30-14-13-20-49(56(63)76)68-54(74)26-31-65-57(77)41(3)66-58(78)42(4)67-59(79)50(37-44-17-9-6-10-18-44)69-55(75)29-34-70-32-27-48(28-33-70)80-52-21-12-11-19-45(52)36-43-15-7-5-8-16-43/h5-12,15-19,21-23,35,38,41-42,48-50H,13-14,20,24-34,36-37H2,1-4H3,(H2,63,76)(H,64,73)(H,65,77)(H,66,78)(H,67,79)(H,68,74)(H,69,75)/t41-,42-,49-,50-/m0/s1
Standard InChI Key: ONHVKLIYWSZJJZ-VYUUOWPSSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1101.12 | Molecular Weight (Monoisotopic): 1100.5830 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Kok ZY, Stoddart LA, Mistry SJ, Mocking TAM, Vischer HF, Leurs R, Hill SJ, Mistry SN, Kellam B.. (2022) Optimization of Peptide Linker-Based Fluorescent Ligands for the Histamine H1 Receptor., 65 (12.0): [PMID:35734860] [10.1021/acs.jmedchem.2c00125] |
Source(1):